Time trends in medication use and expenditures in older patients with rheumatoid arthritis

American Journal of Medicine

Volumn 125, Issue 9, 2012, Pages

  Harrold, Leslie R ^a,b   Peterson, Daniel ^a,b   Beard, Ashley J ^c   Gurwitz, Jerry H ^a,b   Briesacher, Becky A ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Biologic response modifiers; Costs; Disease modifying antirheumatic drugs; Medication; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE;

AGED; ARTICLE; DAILY LIFE ACTIVITY; DRUG COST; DRUG USE; FEMALE; FUNCTIONAL STATUS; HEALTH STATUS; HUMAN; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SELF REPORT;

AGED; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG COSTS; DRUG PRESCRIPTIONS; FEMALE; HEALTH EXPENDITURES; HUMANS; IMMUNOGLOBULIN G; MALE; MEDICARE PART B; MEDICARE PART D; RECEPTORS, TUMOR NECROSIS FACTOR; SAMPLING STUDIES; TIME FACTORS; UNITED STATES;

EID: 84865680779     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.11.014     Document Type: Article

References (36)

1. K.G. Saag, G.G. Teng, N.M. Patkar American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum 59 2008 762 784
2. F.C. Breedveld, M.H. Weisman, A.F. Kavanaugh The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 54 2006 26 37
3. P. Emery, F.C. Breedveld, S. Hall Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial Lancet 372 2008 375 382
4. E.W. St Clair, D.M. van der Heijde, J.S. Smolen Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial Arthritis Rheum 50 2004 3432 3443
5. A. Berard, D.H. Solomon, J. Avorn Patterns of drug use in rheumatoid arthritis J Rheumatol 27 2000 1648 1655
6. C. Carli, A.G. Ehlin, L. Klareskog, S. Lindblad, S.M. Montgomery Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics Ann Rheum Dis 65 2006 1102 1105
7. I. Gonzalez-Alvaro, L. Carmona, A. Balsa, R. Sanmarti, M.A. Belmonte, X. Tena Patterns of disease modifying antirheumatic drug use in a Spanish cohort of patients with rheumatoid arthritis J Rheumatol 30 2003 697 704
8. G. Schmajuk, S. Schneeweiss, J.N. Katz Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal Arthritis Rheum 57 2007 928 934
9. Z. Tutuncu, G. Reed, J. Kremer, A. Kavanaugh Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis 65 2006 1226 1229
10. L. Fraenkel, N. Rabidou, R. Dhar Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford) 45 2006 1555 1557
11. Medicare Payment Advisory Commission Report to the congress: impact of changes in Medicare payments for Part B drugs http://www.medpac.gov/documents/ Jan07-partb-mandated-report.pdf 2007 Accessed January 5, 2011
12. E. Hargrave, J. Hoadley, K. Merrell, J. Cubanski Drugs on Specialty Tiers in Part D: Final Report Washington, DC, 2009 http://www.medpac.gov/documents/ Feb09-DrugsonSpecialtyTiers-CONTRACTOR-RS.pdf Accessed January 14, 2011
13. Office of Inspector General, United States Department of Health and Human Services January 2001 OIG Washington, DC Medicare reimbursement of prescription drugs. OEI-03-00-00310
14. S. Schneeweiss, A.R. Patrick, A. Pedan The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits Health Aff (Millwood) 28 2009 305 316
15. J.M. Polinski, P.E. Mohr, L. Johnson Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis Arthritis Rheum 61 2009 745 754
16. G.S. Adler A profile of the Medicare Current Beneficiary Survey Health Care Financ Rev 15 1994 153 163
17. S.Z. Nagi An epidemiology of disability among adults in the United States Milbank Mem Fund Q Health Soc 54 1976 439-367
18. US Department of Labor Bureau of Labor Statistics: Consumer Price Indexes http://www.bls.gov/cpi/ 2010 Accessed June 1, 2010
19. J.A. Poisal Reporting of drug expenditures in the MCBS Health Care Financ Rev 25 2003 23 36
20. US Census Bureau http://www.census.gov/hhes/www/poverty/methods/ definitions.html Accessed April 20, 2010
21. I.Z. Lurie, D.D. Dunlop, L.M. Manheim Trends in out-of-pocket medical care expenditures for Medicare-age adults with arthritis between 1998 and 2004 Arthritis Rheum 58 2008 2236 2240
22. E. Yelin, L. Murphy, M.G. Cisternas, A.J. Foreman, D.J. Pasta, C.G. Helmick Medical care expenditures and earnings losses among persons with arthritis and other rheumatic conditions in 2003, and comparisons with 1997 Arthritis Rheum 56 2007 1397 1407
23. P. Karaca-Mandic, G.F. Joyce, D.P. Goldman, M. Laouri Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis Health Serv Res 45 5 Pt 1 2010 1227 1250
24. M.O. Leavitt Report to Congress: evaluation of the Medicare replacement drug demonstration Secretary of Health and Human Services https://www.cms.gov/ DemoProjectsEvalRpts/downloads/MMA641-RTC.pdf 2007 Accessed January 14, 2011
25. C. Millett, C.J. Everett, E.M. Matheson, A.B. Bindman, A.G. Mainous 3rd Impact of Medicare Part D on seniors' out-of-pocket expenditures on medications Arch Intern Med 170 2010 1325 1330
26. C.G. Grijalva, C.P. Chung, C.M. Stein, E.F. Mitchel Jr, M.R. Griffin Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population Rheumatology. (Oxford) 47 2008 1061 1064
27. S.J. Lee, H. Chang, Y. Yazici, J.D. Greenberg, J.M. Kremer, A. Kavanaugh Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study J Rheumatol 36 2009 1611 1617
28. Y. Yazici, N. Shi, A. John Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy Bull NYU Hosp Jt Dis 66 2008 77 85
29. H.A. Capell, D.R. Porter, R. Madhok, J.A. Hunter Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient? Ann Rheum Dis 52 1993 423 428
30. G. Gardner, D.E. Furst Disease-modifying antirheumatic drugs Potential effects in older patients Drugs Aging 7 1995 420 437
31. B. Hirshberg, M. Muszkat, O. Schlesinger, A. Rubinow Safety of low dose methotrexate in elderly patients with rheumatoid arthritis Postgrad Med J 76 2000 787 789
32. S. Genevay, A. Finckh, A. Ciurea, A.M. Chamot, D. Kyburz, C. Gabay Tolerance and effectiveness of anti-tumor necrosis factor alpha therapies in elderly patients with rheumatoid arthritis: a population-based cohort study Arthritis Rheum 57 2007 679 685
33. B.J. Radovits, W. Kievit, R.F. Laan Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety Drugs Aging 26 2009 647 664
34. B.J. Radovits, J. Fransen, A. Eijsbouts, P.L. van Riel, R.F. Laan Missed opportunities in the treatment of elderly patients with rheumatoid arthritis Rheumatology (Oxford) 48 2009 906 910
35. J.N. Katz, J. Barrett, M.H. Liang Sensitivity and positive predictive value of Medicare Part B physician claims for rheumatologic diagnoses and procedures Arthritis Rheum 40 1997 1594 1600
36. E. Losina, J. Barrett, J.A. Baron, J.N. Katz Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients J Clin Epidemiol 56 2003 515 519